{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T08:33:31Z","timestamp":1778402011858,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.prro.2022.05.005","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T08:32:33Z","timestamp":1654936353000},"page":"424-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-3248","authenticated-orcid":false,"given":"John","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhanu Prasad","family":"Venkatesulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ksenija","family":"Kujundzic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Katsoulakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek A.","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay L.","family":"Puckett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishabh","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina H.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria D.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatinder","family":"Palta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Ashman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dustin","family":"Jacqmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Kachnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D.","family":"Minsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann C.","family":"Raldow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Y.","family":"Wo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Dawes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randi","family":"Kudner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2022.05.005_bib0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prro.2022.05.005_bib0002","doi-asserted-by":"crossref","first-page":"e1883","DOI":"10.7205\/MILMED-D-16-00371","article-title":"Cancer incidence among patients of the U.S. Veterans Affairs health care system: 2010 update","volume":"182","author":"Zullig","year":"2017","journal-title":"Mil Med"},{"key":"10.1016\/j.prro.2022.05.005_bib0003","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): A multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2022.05.005_bib0004","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): A randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2022.05.005_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.prro.2020.08.004","article-title":"Radiation therapy for rectal cancer: Executive summary of an ASTRO clinical practice guideline","volume":"11","author":"Wo","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2022.05.005_bib0006","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ijrobp.2019.08.064","article-title":"VA-radiation oncology quality surveillance program","volume":"106","author":"Hagan","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.05.005_bib0007","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1245\/s10434-018-6530-6","article-title":"Nationwide heterogeneity in hospital-specific probabilities of rectal cancer understaging and its effects on outcomes","volume":"25","author":"Becerra","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2022.05.005_bib0008","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12885-015-1683-1","article-title":"Do multidisciplinary team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience","volume":"15","author":"Munro","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prro.2022.05.005_bib0009","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.ijrobp.2012.10.015","article-title":"Impact of quality assurance rounds in a Canadian radiation therapy department","volume":"85","author":"Lefresne","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.05.005_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11864-018-0564-7","article-title":"Quality control of radiation delivery for lower gastrointestinal cancers","volume":"19","author":"Jain","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.prro.2022.05.005_bib0011","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijrobp.2015.05.005","article-title":"NRG Oncology Radiation Therapy Oncology Group 0822: A phase II study of preoperative chemoradiotherapy utilizing intensity modulated radiation therapy (IMRT) in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer","volume":"93","author":"Hong","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15_suppl","key":"10.1016\/j.prro.2022.05.005_bib0012","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1200\/JCO.2019.37.15_suppl.3505","article-title":"NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)\u2014First experimental arm (EA) initial results","volume":"37","author":"George","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.05.005_bib0013","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.clcc.2016.02.003","article-title":"PROSPECT eligibility and clinical outcomes: Results from the Pan-Canadian Rectal Cancer Consortium","volume":"15","author":"Boss\u00e9","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.prro.2022.05.005_bib0014","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): A multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2022.05.005_bib0015","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.05.005_bib0016","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tipsro.2019.09.001","article-title":"Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer \u2013 A multicentre dose planning study","volume":"11","author":"Appelt","year":"2019","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.prro.2022.05.005_bib0017","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ijrobp.2013.12.028","article-title":"Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer","volume":"88","author":"Myerson","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.05.005_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rpor.2014.06.003","article-title":"Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma?","volume":"20","author":"Ciria","year":"2014","journal-title":"Rep Pract Oncol Radiother"}],"updated-by":[{"DOI":"10.1016\/j.prro.2023.03.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022001564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022001564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T10:15:30Z","timestamp":1697278530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850022001564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1879850022001564"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2022.05.005","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.prro.2023.03.005","asserted-by":"object"}]},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2022.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}